180 related articles for article (PubMed ID: 25408502)
1. The cytotoxic and pro-apoptotic activities of the novel fluoropyrimidine F10 towards prostate cancer cells are enhanced by Zn(2+) -chelation and inhibiting the serine protease Omi/HtrA2.
Gmeiner WH; Boyacioglu O; Stuart CH; Jennings-Gee J; Balaji KC
Prostate; 2015 Mar; 75(4):360-9. PubMed ID: 25408502
[TBL] [Abstract][Full Text] [Related]
2. [Effects of Omi/HtrA2 on expression of anti-apoptotic protein PED/PEA-15 and apoptosis of prostate cancer cell line PC-3].
Hu XY; Chen XC; Zhu ZH; Chen CH; Zeng FQ; Lu GC
Ai Zheng; 2006 Jun; 25(6):677-82. PubMed ID: 16764760
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of Omi/HtrA2 expression in prostate cancer and benign prostatic hyperplasia.
Hu XY; Xu YM; Chen XC; Ping H; Chen ZH; Zeng FQ
APMIS; 2006 Dec; 114(12):893-8. PubMed ID: 17207090
[TBL] [Abstract][Full Text] [Related]
4. Omi/HtrA2 pro-apoptotic marker differs in various hepatocellular carcinoma cell lines owing to ped/pea-15 expression level.
Xu Z; Chen Y; Xu G; Peng C; Liu E; Li Y; Niu J; Li C
Oncol Rep; 2015 Feb; 33(2):905-12. PubMed ID: 25484138
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of Omi/HtrA2 expression in prostate cancer and benign prostatic hyperplasia.
Hu X; Chen X; Ping H; Chen Z; Zeng F; Lu G
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(6):671-3. PubMed ID: 16696322
[TBL] [Abstract][Full Text] [Related]
6. Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi.
Li W; Srinivasula SM; Chai J; Li P; Wu JW; Zhang Z; Alnemri ES; Shi Y
Nat Struct Biol; 2002 Jun; 9(6):436-41. PubMed ID: 11967569
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways.
Suzuki Y; Takahashi-Niki K; Akagi T; Hashikawa T; Takahashi R
Cell Death Differ; 2004 Feb; 11(2):208-16. PubMed ID: 14605674
[TBL] [Abstract][Full Text] [Related]
8. Participation of Omi Htra2 serine-protease activity in the apoptosis induced by cisplatin on SW480 colon cancer cells.
Pruefer FG; Lizarraga F; Maldonado V; Melendez-Zajgla J
J Chemother; 2008 Jun; 20(3):348-54. PubMed ID: 18606591
[TBL] [Abstract][Full Text] [Related]
9. Zinc pyrithione induces ERK- and PKC-dependent necrosis distinct from TPEN-induced apoptosis in prostate cancer cells.
Carraway RE; Dobner PR
Biochim Biophys Acta; 2012 Feb; 1823(2):544-57. PubMed ID: 22027089
[TBL] [Abstract][Full Text] [Related]
10. The serine protease Omi/HtrA2 is involved in XIAP cleavage and in neuronal cell death following focal cerebral ischemia/reperfusion.
Althaus J; Siegelin MD; Dehghani F; Cilenti L; Zervos AS; Rami A
Neurochem Int; 2007 Jan; 50(1):172-80. PubMed ID: 16978742
[TBL] [Abstract][Full Text] [Related]
11. Akt attenuation of the serine protease activity of HtrA2/Omi through phosphorylation of serine 212.
Yang L; Sun M; Sun XM; Cheng GZ; Nicosia SV; Cheng JQ
J Biol Chem; 2007 Apr; 282(15):10981-7. PubMed ID: 17311912
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a novel and specific inhibitor for the pro-apoptotic protease Omi/HtrA2.
Cilenti L; Lee Y; Hess S; Srinivasula S; Park KM; Junqueira D; Davis H; Bonventre JV; Alnemri ES; Zervos AS
J Biol Chem; 2003 Mar; 278(13):11489-94. PubMed ID: 12529364
[TBL] [Abstract][Full Text] [Related]
13. Omi/HtrA2 promotes cell death by binding and degrading the anti-apoptotic protein ped/pea-15.
Trencia A; Fiory F; Maitan MA; Vito P; Barbagallo AP; Perfetti A; Miele C; Ungaro P; Oriente F; Cilenti L; Zervos AS; Formisano P; Beguinot F
J Biol Chem; 2004 Nov; 279(45):46566-72. PubMed ID: 15328349
[TBL] [Abstract][Full Text] [Related]
14. Chelation of intracellular zinc triggers apoptosis in mature thymocytes.
McCabe MJ; Jiang SA; Orrenius S
Lab Invest; 1993 Jul; 69(1):101-10. PubMed ID: 8331893
[TBL] [Abstract][Full Text] [Related]
15. The applications of the novel polymeric fluoropyrimidine F10 in cancer treatment: current evidence.
Gmeiner WH; Debinski W; Milligan C; Caudell D; Pardee TS
Future Oncol; 2016 Sep; 12(17):2009-20. PubMed ID: 27279153
[TBL] [Abstract][Full Text] [Related]
16. Role of Omi/HtrA2 in apoptotic cell death after myocardial ischemia and reperfusion.
Liu HR; Gao E; Hu A; Tao L; Qu Y; Most P; Koch WJ; Christopher TA; Lopez BL; Alnemri ES; Zervos AS; Ma XL
Circulation; 2005 Jan; 111(1):90-6. PubMed ID: 15611365
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of HTRA2/Omi is associated with infantile neurodegeneration and 3-methylglutaconic aciduria.
Mandel H; Saita S; Edvardson S; Jalas C; Shaag A; Goldsher D; Vlodavsky E; Langer T; Elpeleg O
J Med Genet; 2016 Oct; 53(10):690-6. PubMed ID: 27208207
[TBL] [Abstract][Full Text] [Related]
18. Binding specificity and regulation of the serine protease and PDZ domains of HtrA2/Omi.
Martins LM; Turk BE; Cowling V; Borg A; Jarrell ET; Cantley LC; Downward J
J Biol Chem; 2003 Dec; 278(49):49417-27. PubMed ID: 14512424
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of Omi/HtrA2 expression in stomach cancer.
Lee SH; Lee JW; Kim HS; Kim SY; Park WS; Kim SH; Lee JY; Yoo NJ
APMIS; 2003 May; 111(5):586-90. PubMed ID: 12887511
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific membrane antigen-targeted liposomes specifically deliver the Zn(2+) chelator TPEN inducing oxidative stress in prostate cancer cells.
Stuart CH; Singh R; Smith TL; D'Agostino R; Caudell D; Balaji KC; Gmeiner WH
Nanomedicine (Lond); 2016 May; 11(10):1207-22. PubMed ID: 27077564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
